autologous tSVFem

Autologous tSVFem appears to refer to an autologous cell therapy product, where "autologous" indicates that the cells used are derived from the same individual who will receive the treatment. The abbreviation "tSVFem" is not recognized in standard medical or pharmaceutical literature, and no specific information about its mechanism of action, developer, or primary indication could be found in available sources. Generally, autologous cell therapies involve collecting a patient's own cells (such as stem cells), processing or modifying them outside the body, and then re-infusing them for therapeutic purposes. These therapies are commonly used in oncology (e.g., hematologic malignancies) and regenerative medicine[2][5][8]. Without further context on what "tSVFem" specifically denotes—whether it refers to a particular cell type, modification process, or disease target—the precise description cannot be determined.